However, their role in carcinoids may be more relevant, as these tumours have a low mutational background, whereas carcinomas have a high mutational background and feature inactivation of genes involved in cell cycle control, such as TP53 and RB1 (carcinomas versus carcinoids, p < 0.0001). This evidence concerns the gene RB1 and neoplasm.